NCT07436728 2026-03-27
A Study of TAK-505 in Adults With Solid Tumors
Takeda
Phase 1/2 Not yet recruiting
Clinical Trials
9 trialsNCT06781125 2026-03-24
One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors
Immorna Biotherapeutics, Inc.
Phase 1/2 Not yet recruiting
NCT07028281 2026-03-03
A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2 Recruiting
NCT06629584 2026-02-17
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07268040 2026-01-12
A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 2 Recruiting
NCT06737731 2026-01-09
A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2 Recruiting
NCT07229612 2025-11-17
A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2 Not yet recruiting
NCT02421380 2025-11-06
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT07124195 2025-08-15
Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting
The First Affiliated Hospital of Xinxiang Medical College
Phase 3 Not yet recruiting